Connor, Clark & Lunn Investment Management (CC&L)
UTMD icon

Connor, Clark & Lunn Investment Management (CC&L)’s Utah Medical Products UTMD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,603
Closed -$283K – 1621
2024
Q4 		$283K Sell
4,603
-5,734
-55% -$371K ﹤0.01% 1268
2024
Q3 		$692K Buy
10,337
+4,330
+72% +$294K ﹤0.01% 995
2024
Q2 		$401K Buy
6,007
+1,718
+40% +$117K ﹤0.01% 1107
2024
Q1 		$305K Buy
+4,289
New +$322K ﹤0.01% 1261

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s UTMD Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Utah Medical Products (UTMD) in Q1 2025, closing a stake of 4,603 shares — an estimated $283K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in UTMD in Q1 2024 and held it in 4 quarters. The position peaked at $692K in Q3 2024. 109 funds tracked by Wall St. Rank hold UTMD as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Utah Medical Products position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 4,603 Utah Medical Products shares in Q1 2025, an estimated $283K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Utah Medical Products in Q1 2024 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Utah Medical Products position peaked at $692K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.